IPP Bureau
Commercial disinfectants equally as effective against new COVID strains: CBC
By IPP Bureau - January 13, 2021
Viruses evolve into new strains when there is a change to their genetic composition.
Dr. Reddy’s seeks approval to continue Phase 3 trial
By IPP Bureau - January 13, 2021
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
States need to capture vaccination data: R. S. Sharma
By IPP Bureau - January 11, 2021
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
Biocon Biologics receives US $75 mn from ADQ; Valuation reaches US $4.17 Bn
By IPP Bureau - January 08, 2021
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
